Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy

You may be eligible if

• woman treated with anastrozole as adjuvant therapy for hormone-dependant breast cancer in post-menopausal women with positive hormone-receptors